[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"grant-cancerfonden-next-steps-2026-12":3,"similar-cancerfonden-next-steps-2026-12":34},{"id":4,"name":5,"funder":6,"link":7,"budget":8,"budget_min_eur":8,"budget_max_eur":8,"deadline":9,"deadline_note":8,"duration":8,"trl":10,"relevance":8,"why_relevant":8,"early_career":11,"consortium":12,"first_seen":13,"last_updated":14,"update_note":8,"status":15,"stages":8,"call_frequency":16,"next_call_expected":8,"source_url":7,"created_at":17,"updated_at":18,"eligible_countries":19,"description":21,"seo_summary":22,"recurring_round":11,"canonical_id":4,"links":23},"cancerfonden-next-steps-2026-12","Next steps","Cancerfonden","https:\u002F\u002Fwww.cancerfonden.se\u002Fforskning\u002Ffor-forskare\u002Fsok-anslag-for-forskare\u002Fanvisning-next-steps",null,"2026-12-15T00:00:00.000Z","6-9",false,"Required — utilisation\u002Fcommercialisation partner for implementation or industry uptake","2026-09-06T00:00:00.000Z","2026-09-13T00:00:00.000Z","open","Annual","2026-09-06T07:50:29.022Z","2026-09-13T08:01:57.123Z",[20],"SE","Supports moving promising research results forward towards patient benefit, commercialisation or implementation in healthcare.","{\"summary\":\"Cancerfonden's Next Steps grant funds late-stage cancer research (TRL 6-9) to move promising results toward patient benefit, commercialization, or implementation in Swedish healthcare. It requires a consortium including a utilisation or commercialisation partner to support industry uptake or clinical implementation, and is open to research groups based in Sweden. Cancerfonden runs this call annually.\",\"meta_description\":\"Cancerfonden's Next Steps grant funds late-stage cancer research (TRL 6-9) toward patient benefit and commercialization, for Swedish teams, from Cancerfonden.\",\"who_should_apply\":[\"Research teams with results at TRL 6-9, close to clinical or commercial application\",\"Applicants based at Swedish research institutions\",\"Projects targeting patient benefit, commercialization, or healthcare implementation\",\"Teams able to secure a utilisation or commercialisation partner (industry or implementation partner)\"],\"key_dates\":[\"Deadline: 15 December 2026\",\"Recurring annual call\"],\"tips\":[\"Secure and document your utilisation\u002Fcommercialisation partner early, this consortium requirement is gating, not optional.\",\"Frame the proposal around TRL progression: reviewers expect clarity on where the project sits between 6 and 9 and what milestone it reaches next.\",\"Emphasise the pathway to patient benefit or industry uptake explicitly, since this distinguishes the call from earlier-stage discovery grants.\"],\"faq\":[{\"q\":\"What TRL level does the Cancerfonden Next Steps grant require?\",\"a\":\"Projects should be at TRL 6-9, meaning results are already demonstrated in relevant environments and moving toward real-world application.\"},{\"q\":\"Do I need a partner to apply for Next Steps?\",\"a\":\"Yes, a consortium including a utilisation or commercialisation partner for implementation or industry uptake is required.\"},{\"q\":\"Who is eligible for the Cancerfonden Next Steps grant?\",\"a\":\"Applicants must be based in Sweden, working on cancer research results ready to move toward patient benefit, commercialization, or healthcare implementation.\"},{\"q\":\"Is the Cancerfonden Next Steps grant a recurring call?\",\"a\":\"Yes, it runs annually, with the current deadline set for 15 December 2026.\"}],\"tags\":[\"cancer-biology\",\"cancerfonden\",\"translational-research\",\"commercialization\",\"sweden\",\"late-stage-trl\",\"industry-partnership\",\"consortium-required\"]}",{"matchedProgram":8,"resourceSlug":8,"relatedGuides":24,"countryHubs":25,"domainHubs":29,"closingMonth":30,"hasRelated":11,"hasBrowseRelated":33},[],[26],{"slug":27,"demonym":28},"se","Swedish researchers",[],{"slug":31,"label":32},"2026-12","December 2026",true,{"grants":35},[36,42,46,51,55],{"id":37,"name":38,"funder":39,"deadline":40,"budget":41},"kwf-proof-of-concept-2026-09","Proof of Concept","KWF","2026-09-22T00:00:00.000Z","Up to €150,000 incl. VAT",{"id":43,"name":44,"funder":45,"deadline":8,"budget":8},"aecc-innova-2026","AECC Innova","AECC",{"id":47,"name":48,"funder":39,"deadline":49,"budget":50},"kwf-implementation-of-biomarkers-2026-10","Implementation of Biomarkers","2026-10-20T00:00:00.000Z","€1M–€4M",{"id":52,"name":53,"funder":54,"deadline":8,"budget":8},"cancer-research-uk-drug-development-project-2026","Drug Development Project","Cancer Research UK",{"id":56,"name":57,"funder":58,"deadline":59,"budget":60},"health-holland-sme-call-2027-2026-11","SME Call","Health~Holland","2026-11-20T00:00:00.000Z","€225k–€450k"]